RECRUITING

Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This clinical trial evaluates a golf recreational exercise program for enhancing survivorship in underrepresented prostate cancer survivors. Golf is a multimodal recreational activity that requires participants to utilize all muscle groups to perform the golf swing, walk over hilly and uneven terrain, maintain balance during putting and squat-like tasks. Physical activity and exercise are beneficial to physical function, cognitive function, psychosocial health, and overall quality of life during prostate cancer survivorship. These aspects of health are impacted by prostate cancer treatment, especially androgen deprivation therapy. Additionally, supervised, group-based activity programs facilitate participation in physical activity. Researchers want to examine the changes in functional abilities, psychosocial health, and quality of life following participation in in a golf program designed for prostate cancer survivors.

Official Title

Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors Undergoing Hormone Therapy (GREENS)

Quick Facts

Study Start:2023-09-01
Study Completion:2027-09-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06500169

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:55 Years to 85 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * First time, primary diagnosis of prostate cancer (PCa)
  2. * Currently receiving androgen deprivation therapy (ADT) and/or androgen receptor blocker) for more than 6 months
  3. * Older adult male: 55-85 years old
  4. * The ability to stand independently without external support
  5. * No or minimal golf experience (played \< 5 times in the past 10 years)
  6. * English speaking
  1. * Second cancer diagnosis (excluding non-invasive skin cancers) or bone metastases
  2. * Prostatectomy less than 6 months prior to study enrollment (prostatectomy is not a requirement for study entry)
  3. * Symptomatic cardiovascular disease, active angina, uncontrolled hypertension (systolic blood pressure (SBP) \> 160 or diastolic blood pressure (DBP) \> 90, high resting pulse heart rate (HR) \> 90), symptomatic orthostatic hypotension
  4. * Unstable asthma, exacerbated chronic obstructive pulmonary disease (COPD\]
  5. * History of injury or orthopedic operation within the last 6 months
  6. * Movement disorders (e.g., Parkinson's disease (PD) or other neurological disorders), hemiparesis or paraparesis
  7. * Severe vision or hearing problems

Contacts and Locations

Study Contact

Garry Cai
CONTACT
(323)442-3113
Guanrong@usc.edu

Principal Investigator

George Salem, PhD
PRINCIPAL_INVESTIGATOR
University of Southern California

Study Locations (Sites)

Los Angeles General Medical Center
Los Angeles, California, 90033
United States
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033
United States

Collaborators and Investigators

Sponsor: University of Southern California

  • George Salem, PhD, PRINCIPAL_INVESTIGATOR, University of Southern California

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-01
Study Completion Date2027-09-01

Study Record Updates

Study Start Date2023-09-01
Study Completion Date2027-09-01

Terms related to this study

Additional Relevant MeSH Terms

  • Localized Prostate Carcinoma
  • Locally Advanced Prostate Carcinoma
  • Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8
  • Stage II Prostate Cancer AJCC v8
  • Stage III Prostate Cancer AJCC v8